Hepatitis C News and Research

Latest Hepatitis C News and Research

Domestic PEPFAR program would increase coordination, improve AIDS response in U.S.

"Urban America continues to suffer high rates of HIV despite successes of antiretroviral treatment that can suppress the virus, decrease transmission, prevent progression to AIDS, and lower death rates," Gregory Pappas, senior deputy director of the Washington, D.C., Department of Health's HIV/AIDS, Hepatitis, STD and TB Administration (HAHSTA), writes in a Washington Blade opinion piece.

21 Jul 2012

Janssen-Cilag receives positive opinion from EMA CHMP for DACOGEN

Janssen-Cilag International NV announced today that the Committee for Medical Products for Human Use (CHMP) of the European Medicines Agency (EMA) has granted a positive opinion recommending approval of DACOGEN (decitabine) for Injection.

21 Jul 2012

Silymarin does not offer significant improvements for patients with HCV

Silymarin, an extract of milk thistle commonly used to treat chronic liver disease by millions of people around the World, does not offer significant improvements for patients, according to a new study conducted by a nationwide group of researchers including faculty at the Perelman School of Medicine at the University of Pennsylvania.

20 Jul 2012

Bristol-Myers Squibb reports results from brivanib plus sorafenib phase III trial on HCC

Bristol-Myers Squibb Company today reported the result of the phase III BRISK-FL clinical trial of the investigational agent brivanib versus sorafenib as first-line treatment in patients with advanced hepatocellular carcinoma.

20 Jul 2012

Conatus, University of Alberta initiate islet cell transplant Phase I/II trial of emricasan for diabetes

Conatus Pharmaceuticals Inc. and the University of Alberta announced today the treatment of the first patient in an investigator-initiated islet cell transplant Phase I/II trial of emricasan (IDN-6556), a pan-caspase inhibitor.

20 Jul 2012

AOA honors Medical College of Georgia student with Kuckein Fellowship

A student at the Medical College of Georgia at Georgia Health Sciences University is among 47 recipients of the 2012 Carolyn L. Kuckein Student Research Fellowship from the national medical honor society Alpha Omega Alpha.

19 Jul 2012

Bryologs more potent than prostratin in treating HIV

Thanks to antiretrovirals, an AIDS diagnosis hasn't been a death sentence for nearly two decades. But highly active antiretroviral therapy, or HAART, is also not a cure.

19 Jul 2012

Blog examines potential repercussions of CIA's fake vaccination campaign in Pakistan

In this post on her blog, "The Garrett Update," Laurie Garrett, senior fellow for global health at the Council on Foreign Relations (CFR), examines the potential implications of a fake hepatitis vaccine campaign carried out by the CIA in Pakistan last year in an attempt to gather DNA from Osama bin Laden's family.

19 Jul 2012

HCV infections can lead to increased mortality from liver disease or variety of other causes

In a long-term study of people infected with the hepatitis C virus (HCV), researchers found increased deaths from both liver-related and non-liver related diseases in patients with active infections who had not cleared their infection.

19 Jul 2012

Silymarin does not provide greater benefit for patients with chronic HCV infection

Use of the botanical product silymarin, an extract of milk thistle that is commonly used by some patients with chronic liver disease, did not provide greater benefit than placebo for patients with treatment-resistant chronic hepatitis C virus (HCV) infection, according to a study in the July 18 issue of JAMA.

18 Jul 2012

Hepatitis C treatment may be helped by vitamin B12 supplements

Adding vitamin B12 to standard hepatitis C virus (HCV) treatment significantly boosts the body’s ability to keep the virus at bay, indicates a pilot study published online in the journal Gut.

18 Jul 2012

Smoking, hepatitis and liver transplantation: An interview with Dr Peter Ghali

We are very interested in hepatitis C as it is the most common indication for liver transplant in the Western world. The difficulty is that recurrence happens in the majority of patients within the first 2 to 7 years after transplant, and occasionally sooner.

18 Jul 2012

Johnson & Johnson second quarter sales decrease 0.7% to $16.5B

Johnson & Johnson today announced sales of $16.5 billion for the second quarter of 2012, a decrease of 0.7% as compared to the second quarter of 2011. Operational results increased 3.5% and the negative impact of currency was 4.2%.

17 Jul 2012

Helper T cells may be frontline warriors when battling hepatitis A infection

Helper cells traditionally thought to only assist killer white blood cells may be the frontline warriors when battling hepatitis A infection. These are the findings from a Nationwide Children's Hospital study appearing in a recent issue of the Journal of Experimental Medicine.

17 Jul 2012

Activating NOTCH and AKT gene may trigger cholangiocarcinoma

A rare type of cancer thought to derive from cells in the bile ducts of the liver may actually develop when one type of liver cell morphs into a totally different type, a process scientists used to consider all but impossible. UCSF researchers triggered this kind of cellular transformation-and caused tumors to form in mice-by activating just two genes.

17 Jul 2012

CDC launches Let's Stop HIV Together campaign

To combat two major obstacles to HIV prevention—stigma associated with the infection and complacency about the epidemic—the Centers for Disease Control and Prevention today launched Let's Stop HIV Together, a national communication campaign that gives voice to Americans living with HIV, and to their loved ones.

17 Jul 2012

Johns Hopkins doctoral program graduate explores ways to control infectious diseases

Her passport is stamped with exotic locations: Myanmar, Tibet, South Africa, Vietnam, and Cambodia, as well as Baltimore, MD. But, when Carrie Tudor, PhD, MPH, RN, looks at it, she sees global battlefields in the fight against infectious disease. Her weapons: immunizations, programs to curb tuberculosis and HIV transmission, and a drive to carry on a rich tradition of public health nursing research.

16 Jul 2012

College-age children also need immunizations, says UMDNJ professor

Most parents take their young children regularly for immunization shots that protect against polio, diphtheria, measles, mumps and other diseases. But many do not consider that their college-age children also need immunizations.

14 Jul 2012

Smokers at risk for recurrent hepatitis post-liver transplantation

Transplant recipients who smoke or have smoked increase their risk of viral hepatitis reinfection following liver transplantation according to new research available in the July issue of Liver Transplantation, a journal published by Wiley on behalf of American Association for the Study of Liver Diseases.

12 Jul 2012

HIV and AIDS treatment: An interview with Charles Flexner, MD

The best estimates at the moment reckon that there are about 25 million people infected with HIV. Most of those are in resource-limited settings, including sub-Saharan Africa, South East Asia and India.

11 Jul 2012

Hepatitis C News and Research

Latest Hepatitis C News and Research

Domestic PEPFAR program would increase coordination, improve AIDS response in U.S.

Janssen-Cilag receives positive opinion from EMA CHMP for DACOGEN

Silymarin does not offer significant improvements for patients with HCV

Bristol-Myers Squibb reports results from brivanib plus sorafenib phase III trial on HCC

Conatus, University of Alberta initiate islet cell transplant Phase I/II trial of emricasan for diabetes

AOA honors Medical College of Georgia student with Kuckein Fellowship

Bryologs more potent than prostratin in treating HIV

Blog examines potential repercussions of CIA's fake vaccination campaign in Pakistan

HCV infections can lead to increased mortality from liver disease or variety of other causes

Silymarin does not provide greater benefit for patients with chronic HCV infection

Hepatitis C treatment may be helped by vitamin B12 supplements

Smoking, hepatitis and liver transplantation: An interview with Dr Peter Ghali

Johnson & Johnson second quarter sales decrease 0.7% to $16.5B

Helper T cells may be frontline warriors when battling hepatitis A infection

Activating NOTCH and AKT gene may trigger cholangiocarcinoma

CDC launches Let's Stop HIV Together campaign

Johns Hopkins doctoral program graduate explores ways to control infectious diseases

College-age children also need immunizations, says UMDNJ professor

Smokers at risk for recurrent hepatitis post-liver transplantation

HIV and AIDS treatment: An interview with Charles Flexner, MD

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Hepatitis C News and Research

Latest Hepatitis C News and Research

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Newsletters you may be interested in